News
The Food & Beverage sector maintained its leadership position with a 22% share of total ad volumes, followed by the personal ...
1d
TipRanks on MSNGSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer Treatment
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...
U.S. District Judge Paul Diamond, of the Eastern District of Pennsylvania, said he was considering sanctions against Steve ...
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...
Haleon (erstwhile GlaxoSmithKline Consumer Healthcare) and the Indian Dental Association (IDA) successfully partnered to ...
Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...
Over 100 employees from GSK’s Hamilton site recently rolled up their sleeves for their annual "Together Days," a volunteer ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
President Trump sent letters Thursday to 17 of the world’s largest drug companies, telling them to take more steps to slash ...
8d
TipRanks on MSNGlaxoSmithKline Reports Strong Q2 2025 Performance
GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results